Literature DB >> 30956495

Ovarian Small Cell Carcinoma of Hypercalcemic Type in an Adolescent Girl.

Divya Khosla1, Nalini Gupta2, Abin Koshy1, Ashwani Dalal1, A K Pandey3, Kislay Dimri1.   

Abstract

OBJECTIVE: Small cell carcinoma of ovary, hypercalcemic type is a rare malignancy with a dismal prognosis. The diagnosis is often confused with many other tumors. CASE REPORT: We describe a rare case of ovarian small cell carcinoma of hypercalcemic type in an adolescent. She presented with abdominal pain, awareness of mass and vomiting. She underwent exploratory laparotomy and right ovarian excision. The detailed histopathological examination including immunohistochemistry was suggestive of ovarian small cell carcinoma of hypercalcemic type. She had progressive disease on chemotherapy and ultimately died within 2 years of diagnosis. Due to rarity of this neoplasm and its aggressive nature, the optimal treatment regimen has not been established.
CONCLUSION: We report this case because of its rare occurrence leading to clinical and diagnostic challenges and need to explore effective treatment options to improve survival in these patients.

Entities:  

Keywords:  Adolescent; Chemotherapy; Hypercalcemia; Rhabdoid; Small cell carcinoma

Year:  2018        PMID: 30956495      PMCID: PMC6431709          DOI: 10.1007/s13224-018-1091-y

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  10 in total

1.  Ovarian small cell carcinoma of the hypercalcemic type in a 14 month old: the youngest reported case.

Authors:  S R Florell; C S Bruggers; M Matlak; R H Young; A Lowichik
Journal:  Med Pediatr Oncol       Date:  1999-04

2.  Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.

Authors:  M L Harrison; P Hoskins; A du Bois; M Quinn; G J S Rustin; J A Ledermann; S Baron-Hay; M L Friedlander
Journal:  Gynecol Oncol       Date:  2006-02       Impact factor: 5.482

3.  Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.

Authors:  Blaise A Clarke; Leora Witkowski; Tuyet N Ton Nu; Patricia A Shaw; C Blake Gilks; David Huntsman; Anthony N Karnezis; Neil Sebire; Janez Lamovec; Lawrence M Roth; Colin J R Stewart; Martin Hasselblatt; William D Foulkes; W Glenn McCluggage
Journal:  Histopathology       Date:  2016-07-28       Impact factor: 5.087

4.  Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary.

Authors:  E K Senekjian; P A Weiser; A Talerman; A L Herbst
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

5.  SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.

Authors:  Abbas Agaimy; Falk Thiel; Arndt Hartmann; Masaharu Fukunaga
Journal:  Ann Diagn Pathol       Date:  2015-06-09       Impact factor: 2.090

6.  Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type.

Authors:  P Pautier; V Ribrag; P Duvillard; A Rey; I Elghissassi; I Sillet-Bach; P Kerbrat; F Mayer; A Lesoin; B Brun; H Crouet; J C Barats; P Morice; C Lhommé
Journal:  Ann Oncol       Date:  2007-08-30       Impact factor: 32.976

7.  Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases.

Authors:  R H Young; E Oliva; R E Scully
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

8.  Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases.

Authors:  G R Dickersin; I W Kline; R E Scully
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

9.  Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

Authors:  D Callegaro-Filho; D M Gershenson; A M Nick; M F Munsell; P T Ramirez; P J Eifel; E D Euscher; R M Marques; S M Nicolau; K M Schmeler
Journal:  Gynecol Oncol       Date:  2015-11-04       Impact factor: 5.482

10.  Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary.

Authors:  John J Wallbillich; Alpa M Nick; Pedro T Ramirez; Jack L Watkins; Elizabeth D Euscher; Kathleen M Schmeler
Journal:  Gynecol Oncol Case Rep       Date:  2012-02-13
  10 in total
  1 in total

1.  Ovarian small cell carcinoma by ovarian torsion feature: A cytopathology challenging case.

Authors:  Fatemeh Keikha; Alireza Hadizadeh; Setareh Akhavan; Fatemeh Nili; Arefeh Eshghinejad; Marjan Ghaemi
Journal:  Int J Surg Case Rep       Date:  2022-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.